BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37041541)

  • 1. The influence of demographic, health and psychosocial factors on patient uptake of the English NHS diabetes prevention programme.
    Reeves D; Woodham AA; French D; Bower P; Holland F; Kontopantelis E; Cotterill S
    BMC Health Serv Res; 2023 Apr; 23(1):352. PubMed ID: 37041541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influences on Patient Uptake of and Engagement With the National Health Service Digital Diabetes Prevention Programme: Qualitative Interview Study.
    Ross J; Cotterill S; Bower P; Murray E
    J Med Internet Res; 2023 Feb; 25():e40961. PubMed ID: 36853751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake and impact of the English National Health Service digital diabetes prevention programme: observational study.
    Ross JAD; Barron E; McGough B; Valabhji J; Daff K; Irwin J; Henley WE; Murray E
    BMJ Open Diabetes Res Care; 2022 May; 10(3):. PubMed ID: 35504697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stakeholders' perceptions and experiences of the National Health Service diabetes prevention programme in England: qualitative study with service users, intervention providers and deliverers, commissioners and referrers.
    Rodrigues AM; Haste A; Penn L; Bell R; Summerbell C; White M; Adamson AJ; Sniehotta FF
    BMC Health Serv Res; 2020 Apr; 20(1):307. PubMed ID: 32293424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NHS Diabetes Prevention Programme: an observational study of service delivery and patient experience.
    Hawkes RE; Cameron E; Cotterill S; Bower P; French DP
    BMC Health Serv Res; 2020 Nov; 20(1):1098. PubMed ID: 33246460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NHS Diabetes Prevention Programme in England: formative evaluation of the programme in early phase implementation.
    Penn L; Rodrigues A; Haste A; Marques MM; Budig K; Sainsbury K; Bell R; Araújo-Soares V; White M; Summerbell C; Goyder E; Brennan A; Adamson AJ; Sniehotta FF
    BMJ Open; 2018 Feb; 8(2):e019467. PubMed ID: 29467134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Referral to the NHS Diabetes Prevention Programme and conversion from nondiabetic hyperglycaemia to type 2 diabetes mellitus in England: A matched cohort analysis.
    Ravindrarajah R; Sutton M; Reeves D; Cotterill S; Mcmanus E; Meacock R; Whittaker W; Soiland-Reyes C; Heller S; Bower P; Kontopantelis E
    PLoS Med; 2023 Feb; 20(2):e1004177. PubMed ID: 36848393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the design of the NHS Diabetes Prevention Programme intervention have fidelity to the programme specification? A document analysis.
    Hawkes RE; Cameron E; Bower P; French DP
    Diabet Med; 2020 Aug; 37(8):1357-1366. PubMed ID: 31808578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and Early Use of the Nationally Implemented Healthier You National Health Service Digital Diabetes Prevention Programme: Mixed Methods Study.
    Ross J; Hawkes RE; Miles LM; Cotterill S; Bower P; Murray E
    J Med Internet Res; 2023 Aug; 25():e47436. PubMed ID: 37590056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study.
    Barron E; Misra S; English E; John WG; Sampson M; Bachmann MO; Barth J; Oliver N; Alberti KGMM; Bakhai C; O'Neill S; Young B; Wareham NJ; Khunti K; Jebb S; Smith J; Valabhji J
    BMJ Open Diabetes Res Care; 2020 Dec; 8(2):. PubMed ID: 33318069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The English national health service diabetes prevention programme (NHS DPP): A scoping review of existing evidence.
    Whelan M; Bell L
    Diabet Med; 2022 Jul; 39(7):e14855. PubMed ID: 35441747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could diabetes prevention programmes result in the widening of sociodemographic inequalities in type 2 diabetes? Comparison of survey and administrative data for England.
    Chatzi G; Whittaker W; Chandola T; Mason T; Soiland-Reyes C; Sutton M; Bower P
    J Epidemiol Community Health; 2023 Sep; 77(9):565-570. PubMed ID: 37353312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the NHS Diabetes Prevention Programme Intervention Delivered as Planned? An Observational Study of Fidelity of Intervention Delivery.
    French DP; Hawkes RE; Bower P; Cameron E
    Ann Behav Med; 2021 Oct; 55(11):1104-1115. PubMed ID: 33580647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Going the distance': an independent cohort study of engagement and dropout among the first 100 000 referrals into a large-scale diabetes prevention program.
    Howarth E; Bower PJ; Kontopantelis E; Soiland-Reyes C; Meacock R; Whittaker W; Cotterill S
    BMJ Open Diabetes Res Care; 2020 Dec; 8(2):. PubMed ID: 33303493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The theoretical basis of a nationally implemented type 2 diabetes prevention programme: how is the programme expected to produce changes in behaviour?
    Hawkes RE; Miles LM; French DP
    Int J Behav Nutr Phys Act; 2021 May; 18(1):64. PubMed ID: 33985524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediabetes, participation in the English National Health Service Diabetes Prevention Programme, and associations with COVID-19-related mortality: A whole population study.
    Barron E; Sharp SJ; Khunti K; Bakhai C; Wareham NJ; Valabhji J
    Diabetes Res Clin Pract; 2024 Jun; 212():111692. PubMed ID: 38723673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
    Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
    BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of digital and remote provision of the Healthier You: NHS Diabetes Prevention Programme during the COVID-19 pandemic.
    Barron E; Bradley D; Safazadeh S; McGough B; Bakhai C; Young B; Khunti K; Murray E; Wareham N; Jebb S; Valabhji J
    Diabet Med; 2023 May; 40(5):e15028. PubMed ID: 36524707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling tool to support decision-making in the NHS Health Check programme: workshops, systematic review and co-production with users.
    O'Flaherty M; Lloyd-Williams F; Capewell S; Boland A; Maden M; Collins B; Bandosz P; Hyseni L; Kypridemos C
    Health Technol Assess; 2021 May; 25(35):1-234. PubMed ID: 34076574
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.